Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms

Lucijanic, Marko; Krečak, Ivan

doi:10.1007/s11239-023-02779-w

prikaz prve stranice dokumenta Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms

Access restricted to students and staff of home institution

Professional paper - Letter to the editor

Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms

Journal of Thrombosis and Thrombolysis, 55 (2023), 4; 760-761. https://doi.org/10.1007/s11239-023-02779-w

Lucijanic, Marko; Krečak, Ivan

Request a copy
of the document

Cite this document

APA 6th Edition

Lucijanic, M. & Krečak, I. (2023). Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms. Journal of Thrombosis and Thrombolysis, 55. (4), 760-761. doi: 10.1007/s11239-023-02779-w

MLA 8th Edition

Lucijanic, Marko and Ivan Krečak. "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms." Journal of Thrombosis and Thrombolysis, vol. 55, no. 4, 2023, pp. 760-761. https://doi.org/10.1007/s11239-023-02779-w

Chicago 17th Edition

Lucijanic, Marko and Ivan Krečak. "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms." Journal of Thrombosis and Thrombolysis 55, no. 4 (2023): 760-761. https://doi.org/10.1007/s11239-023-02779-w

Harvard

Lucijanic, M. and Krečak, I. (2023) 'Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms', Journal of Thrombosis and Thrombolysis, 55(4), pp. 760-761. doi: 10.1007/s11239-023-02779-w

Vancouver

Lucijanic M, Krečak I. Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms. Journal of Thrombosis and Thrombolysis [Internet]. 2023 February 06 [cited 2024 December 02];55(4):760-761. doi: 10.1007/s11239-023-02779-w

IEEE

M. Lucijanic and I. Krečak, "Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms", Journal of Thrombosis and Thrombolysis, vol. 55, no. 4, pp. 760-761, February 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:890614. [Accessed: 02 December 2024]

Cite this item: https://urn.nsk.hr/urn:nbn:hr:184:890614

Please login to the repository to save this object to your list.

Metadata

Title (english)	Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms
Author	Marko Lucijanic
Author	Ivan Krečak
Author's institution	University of Rijeka Faculty of Medicine (Department of Internal Medicine)
Scientific / art field, discipline and subdiscipline	BIOMEDICINE AND HEALTHCARE Clinical Medical Sciences Internal Medicine
Language	english
Publication type	Professional paper - Letter to the editor
Publication status	Published
Peer review	Peer review - international
Publication version	Published version
Journal title	Journal of Thrombosis and Thrombolysis
Numbering	vol. 55, no. 4, pp. 760-761
e-ISSN	1573-742X
DOI	https://doi.org/10.1007/s11239-023-02779-w
URN:NBN	urn:nbn:hr:184:890614
Publication	2023-02-06
Document URL	https://link.springer.com/10.1007/s11239-023-02779-w
Type of resource	Text
Access conditions	Institutional access
Terms of use
Created on	2023-05-03 06:09:37